Polymorphisms of the androgen transporting gene SLCO2B1 and response to abiraterone acetate in mCRPC patients.

被引：3
|
作者：
Giacinti, Silvana
Bassanelli, Maria
Roberto, Michela
Strigari, Lidia
De Nunzio, Cosimo
Aschelter, Anna Maria
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
174
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation
    N Fujimoto
    T Kubo
    H Inatomi
    H T T Bui
    M Shiota
    T Sho
    T Matsumoto
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 336 - 340
  • [2] Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation
    Fujimoto, N.
    Kubo, T.
    Inatomi, H.
    Bui, H. T. T.
    Shiota, M.
    Sho, T.
    Matsumoto, T.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) : 336 - 340
  • [3] POLYMORPHISMS OF ANDROGEN TRANSPORTING GENE SLCO1B3 AND SLCO2B1 MAY PARTICIPATE IN HORMONE-RESISTANCE AND ETHNIC DIFFERENCE IN RESPONSE OF PROSTATE CANCER TO ANDROGEN DEPRIVATION THERAPY
    Fujimoto, Naohiro
    Kubo, Tatsuhiko
    Bui, Hoai
    Tomisaki, Ikko
    Matsumoto, Tetsuro
    JOURNAL OF UROLOGY, 2013, 189 (04): : E392 - E392
  • [4] Germline variant in SLCO2B1 and response to abiraterone acetate plus prednisone (AA) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Hahn, Andrew W.
    Patel, Darshan
    Gill, David Michael
    Froerer, Camryn
    Nussensveig, Roberto
    Poole, Austin
    Hale, Peter
    Farnham, James M.
    Maughan, Benjamin Louis
    Cannon-Albright, Lisa A.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Germline variant alleles in rs12422149 of SLCO2B1 and response to abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Hahn, Andrew W.
    Gill, David Michael
    Hale, Peter
    Poole, Austin
    Nussenzveig, Roberto
    Wilson, Sara
    Farnham, James M.
    Stephenson, Robert A.
    Maughan, Benjamin Louis
    Cannon-Albright, Lisa
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC)
    Hahn, Andrew W.
    Gill, David M.
    Poole, Austin
    Nussenzveig, Roberto H.
    Wilson, Sara
    Farnham, James M.
    Stephenson, Robert A.
    Cannon-Albright, Lisa A.
    Maughan, Benjamin L.
    Agarwal, Neeraj
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (03) : 726 - 729
  • [7] Effects of Polymorphisms of the SLCO2B1 Transporter Gene on the Pharmacokinetics of Montelukast in Humans
    Kim, Kyoung-Ah
    Lee, Hye-Mi
    Joo, Hyun-Jin
    Park, In-Bae
    Park, Ji-Young
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1186 - 1193
  • [8] Genetic Polymorphisms in SLCO1B3 and SLCO2B1 May Influence the Racial Difference in the Response to Androgen Deprivation Therapy in Advanced Prostate Cancer
    Fujimoto, N.
    Kubo, T.
    Inatomi, H.
    Hoai, B.
    Yoshida, T.
    Shiota, M.
    Matsumoto, T.
    UROLOGY, 2012, 80 (03) : S80 - S80
  • [9] SLCO1B1, SLCO2B1, and SLCO1B3 Polymorphisms and Susceptibility to Bladder Cancer Risk
    Hoai Thi Thu Bui
    Fujimoto, Naohiro
    Kubo, Tatsuhiko
    Inatomi, Hisato
    Matsumoto, Tetsuro
    CANCER INVESTIGATION, 2014, 32 (06) : 256 - 261
  • [10] SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
    Sortica, Vinicius A.
    Lindenau, Juliana D.
    Cunha, Maristela G.
    Ohnishi, Maria Deise O.
    Ventura, Ana Maria R.
    Ribeiro-dos-Santos, A. ndrea K. C.
    Santos, Sidney E. B.
    Guimaraes, Luciano S. P.
    Hutz, Mara H.
    PHARMACOGENOMICS, 2017, 18 (15) : 1401 - 1411
12345